What Clinicians Need to Know About the Development of Long-Acting Formulations.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 36410382.
- Also identified by DOI 10.1093/cid/ciac749 and PMC identifier 10200319.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We encourage readers of this Supplement to find articles that are relevant to the current and future practice of infectious diseases medicine. Access to long-acting products and formulations in low- and middle-income countries remains a key determinant of the impact of these advances on global health.
Medical subject headings
- Drug Compounding